| Johnson & Johnson | 1.01M | US$255M | 22.4% |
| Eli Lilly And Company | 211K | US$253M | 22.2% |
| Merck & Company, Inc. | 403K | US$51.8M | 4.5% |
| Bristol-myers Squibb Company | 863K | US$49.7M | 4.4% |
| Royalty Pharma Plc | 880K | US$49.3M | 4.3% |
| Viatris Inc. | 3.03M | US$48M | 4.2% |
| Pfizer, Inc. | 1.87M | US$45.1M | 4.0% |
| Zoetis Inc. | 590K | US$42.4M | 3.7% |
| Jazz Pharmaceuticals Plc | 163K | US$39.3M | 3.5% |
| Elanco Animal Health Incorporated | 1.3M | US$31.9M | 2.8% |
| Axsome Therapeutics, Inc. | 112K | US$27.5M | 2.4% |
| Corcept Therapeutics Incorporated | 248K | US$21.6M | 1.9% |
| Ligand Pharmaceuticals Incorporated | 52,070 | US$16.5M | 1.4% |
| Definium Therapeutics, Inc. | 336K | US$15.8M | 1.4% |
| Liquidia Corporation | 183K | US$14.6M | 1.3% |
| Indivior Pharmaceuticals, Inc. | 317K | US$13M | 1.1% |
| Crinetics Pharmaceuticals, Inc. | 274K | US$10.3M | 0.90% |
| Organon & Co. | 683K | US$9.25M | 0.81% |
| Edgewise Therapeutics, Inc. | 196K | US$7.96M | 0.70% |
| Amneal Pharmaceuticals, Inc. | 448K | US$7.76M | 0.68% |
| Enliven Therapeutics, Inc. | 141K | US$7.18M | 0.63% |
| Supernus Pharmaceuticals, Inc. | 151K | US$7.02M | 0.62% |
| Tarsus Pharmaceuticals, Inc. | 103K | US$6.47M | 0.57% |
| Veradermics, Incorporated | 52,065 | US$6.4M | 0.56% |
| Alumis Inc. | 222K | US$6.23M | 0.55% |
| Nektar Therapeutics | 87,878 | US$6.13M | 0.54% |
| Prestige Consumer Healthcare Inc. | 123K | US$5.81M | 0.51% |
| Trevi Therapeutics, Inc. | 307K | US$5.72M | 0.50% |
| Ocular Therapeutix, Inc. | 455K | US$4.47M | 0.39% |
| Innoviva, Inc. | 182K | US$4.14M | 0.36% |
| Amylyx Pharmaceuticals, Inc. | 220K | US$3.94M | 0.35% |
| Ani Pharmaceuticals, Inc. | 47,404 | US$3.92M | 0.34% |
| Mbx Biosciences, Inc. | 69,247 | US$3.82M | 0.34% |
| Harmony Biosciences Holdings, Inc. | 104K | US$3.78M | 0.33% |
| Perrigo Company Plc | 360K | US$3.74M | 0.33% |
| Harrow, Inc. | 86,214 | US$3.66M | 0.32% |
| Nuvation Bio Inc. | 634K | US$3.6M | 0.32% |
| Xeris Biopharma Holdings, Inc. | 449K | US$3.55M | 0.31% |
| Rapport Therapeutics, Inc. | 74,520 | US$3.11M | 0.27% |
| Collegium Pharmaceutical, Inc. | 84,237 | US$3.05M | 0.27% |
| Eyepoint, Inc. | 205K | US$2.93M | 0.26% |
| Ataibeckley Inc. | 506K | US$2.67M | 0.23% |
| Pacira Biosciences, Inc. | 102K | US$2.59M | 0.23% |
| Wave Life Sciences Ltd. | 394K | US$2.29M | 0.20% |
| Maze Therapeutics, Inc. | 73,160 | US$2.18M | 0.19% |
| Lb Pharmaceuticals Inc | 63,173 | US$2.05M | 0.18% |
| Bioage Labs, Inc. | 82,938 | US$2.03M | 0.18% |
| Septerna, Inc. | 59,605 | US$2M | 0.18% |
| Amphastar Pharmaceuticals, Inc. | 88,493 | US$1.79M | 0.16% |
| Omeros Corporation | 188K | US$1.78M | 0.16% |
| Phibro Animal Health Corporation | 54,917 | US$1.72M | 0.15% |
| Theravance Biopharma, Inc. | 98,073 | US$1.67M | 0.15% |
| Cormedix Inc. | 190K | US$1.49M | 0.13% |
| Phathom Pharmaceuticals, Inc. | 133K | US$1.44M | 0.13% |
| Arvinas, Inc. | 168K | US$1.4M | 0.12% |
| Evolus, Inc. Common Stock | 172K | US$1.19M | 0.10% |
| Lenz Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |